Hot chilli may be the key to lose weight, say Adelaide University researchers

University of Adelaide researchers have discovered a high-fat diet may impair important receptors located in the stomach that signal fullness.

Published today in the journal PLOS ONE, researchers from the University's Centre for Nutrition and Gastrointestinal Diseases (based at the South Australian Health and Medical Research Institute) investigated the association between hot chilli pepper receptors (TRPV1) in the stomach and the feeling of fullness, in laboratory studies.

"The stomach stretches when it is full, which activates nerves in the stomach to tell the body that it has had enough food. We found that this activation is regulated through hot chilli pepper or TRPV1 receptors," says Associate Professor Amanda Page, Senior Research Fellow in the University of Adelaide's School of Medicine and lead author on the paper.

"It is known from previous studies that capsaicin, found in hot chillies, reduces food intake in humans. And what we've discovered is that deletion of TRPV1 receptors dampens the response of gastric nerves to stretch - resulting in a delayed feeling of fullness and the consumption of more food. Therefore part of the effect of capsaicin on food intake may be mediated via the stomach.

"We also found that TRPV1 receptors can be disrupted in high fat diet induced obesity," she says.

Dr Stephen Kentish says these findings will inform further studies and the development of new therapies.

"It's exciting that we now know more about the TRPV1 receptor pathway and that the consumption of capsaicin may be able to prevent overeating through an action on nerves in the stomach," says Dr Kentish, National Health and Medical Research Council (NHMRC) Fellow from the University of Adelaide's School of Medicine.

"The next stage of research will involve investigation of the mechanisms behind TRPV1 receptor activation with the aim of developing a more palatable therapy.

"We will also do further work to determine why a high-fat diet de-sensitises TRPV1 receptors and investigate if we can reverse the damage," he says.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study aims to reduce C-section rates in pregnant women with obesity